Hubert Schrezenmeier
Hubert Schrezenmeier
University of Ulm & German Red Cross Blood Transfusion Service Baden-Württemberg - Hessen
Bestätigte E-Mail-Adresse bei blutspende.de
TitelZitiert vonJahr
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria
P Hillmen, NS Young, J Schubert, RA Brodsky, G Socié, P Muus, A Röth, ...
New England Journal of Medicine 355 (12), 1233-1243, 2006
9342006
T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells.
B Fleischer, H Schrezenmeier
Journal of Experimental Medicine 167 (5), 1697-1707, 1988
5081988
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
P Hillmen, P Muus, U Dührsen, AM Risitano, J Schubert, L Luzzatto, ...
Blood 110 (12), 4123-4128, 2007
4832007
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
RA Brodsky, NS Young, E Antonioli, AM Risitano, H Schrezenmeier, ...
Blood 111 (4), 1840-1847, 2008
4812008
Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men
E Späth-Schwalbe, K Hansen, F Schmidt, H Schrezenmeier, L Marshall, ...
The Journal of Clinical Endocrinology & Metabolism 83 (5), 1573-1579, 1998
4421998
Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine
N Frickhofen, JP Kaltwasser, H Schrezenmeier, A Raghavachar, HG Vogt, ...
New England Journal of Medicine 324 (19), 1297-1304, 1991
4401991
Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia
N Frickhofen, H Heimpel, JP Kaltwasser, H Schrezenmeier
Blood 101 (4), 1236-1242, 2003
4092003
Mesenchymal stem cells for clinical application
L Sensebe, M Krampera, H Schrezenmeier, P Bourin, R Giordano
Vox sanguinis 98 (2), 93-107, 2010
3192010
Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European …
A Locasciulli, R Oneto, A Bacigalupo, G Socié, E Korthof, A Bekassy, ...
Haematologica 92 (1), 11-18, 2007
3172007
Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy-The European Group for Blood and Marrow Transplantation experience
A Bacigalupo, R Brand, R Oneto, B Bruno, G Sodé, J Passweg, ...
Seminars in hematology 37 (1), 69-80, 2000
3152000
Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells
MR Lorenz, V Holzapfel, A Musyanovych, K Nothelfer, P Walther, H Frank, ...
Biomaterials 27 (14), 2820-2828, 2006
3052006
Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation
MC Florian, K Dörr, A Niebel, D Daria, H Schrezenmeier, M Rojewski, ...
Cell stem cell 10 (5), 520-530, 2012
2772012
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired …
H Schrezenmeier, JR Passweg, JCW Marsh, A Bacigalupo, CN Bredeson, ...
Blood 110 (4), 1397-1400, 2007
2672007
A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage
J Wang, Q Sun, Y Morita, H Jiang, A Groß, A Lechel, K Hildner, ...
Cell 148 (5), 1001-1014, 2012
2632012
Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells
J Dausend, A Musyanovych, M Dass, P Walther, H Schrezenmeier, ...
Macromolecular bioscience 8 (12), 1135-1143, 2008
2622008
Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria
P Hillmen, P Muus, A Röth, MO Elebute, AM Risitano, H Schrezenmeier, ...
British journal of haematology 162 (1), 62-73, 2013
2462013
Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere …
J Marsh, H Schrezenmeier, P Marin, O Ilhan, P Ljungman, S McCann, ...
Blood 93 (7), 2191-2195, 1999
2301999
Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow …
N Fekete, M Gadelorge, D Fürst, C Maurer, J Dausend, ...
Cytotherapy 14 (5), 540-554, 2012
2052012
A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of …
H Schrezenmeier, B Hertenstein, B Wagner, A Raghavachar, H Heimpel
Experimental hematology 23 (1), 81-87, 1995
1701995
A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of …
A Tichelli, H Schrezenmeier, G Socié, J Marsh, A Bacigalupo, U Dührsen, ...
Blood 117 (17), 4434-4441, 2011
1692011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20